Passage Bio's total assets for Q1 2026 were $36.46M, a decrease of -41.46% from the previous quarter. PASG total liabilities were $24.71M for the fiscal quarter, a -43.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.